04
Jun

In May, Synpromics attended the ASGCT annual general meeting in Chicago.

31
May
Flavia Scialpi

Making the step from academia into industry can seem daunting and can appear to require a very different skill set.

10
May

In April, Synpromics attended the 6th annual Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day in New York, a full-day conference featuring discussi

15
Mar
ASGCT banner

As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged.

12
Mar
BioCentury Innovations

Bringing synthetic biology to transcriptional regulation could catalyse a new generation of gene therapies that are more tunable, disease-specific and easy to deliver than the products dominating the field.

Pages